CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer

BACKGROUND: Most patients with high-grade serous ovarian cancer (HGSC) lack an effective response to immune checkpoint blockade, highlighting the need for more knowledge about what is required for successful treatment. As follicular cytotoxic CXCR5(+)CD8(+) T cells are maintained by reinvigoration b...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Immunother Cancer
Autori principali: Yang, Moran, Lu, Jiaqi, Zhang, Guodong, Wang, Yiying, He, Mengdi, Xu, Qing, Xu, Congjian, Liu, Haiou
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2021
Soggetti:
Immunotherapy Biomarkers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7813306/
https://ncbi.nlm.nih.gov/pubmed/33452206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001136
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi